Tag: Biogen
Health: An Unusual Split Within US Govt over Alzheimer’s Treatment
The Story:
Last week, Medicare announced an unusually strict decision about treatment of a Biogen Alzheimer's drug, Aduhelm. Medicare, which is the U.S. health plan...
Health: Biogen Invests in ALS Project
The Story:
Last week, pharmaceutical giant Biogen Inc. and start-up Scribe Therapeutics announced a joint project to develop therapies for amyotrophic lateral sclerosis (ALS), also...
Health: Priority Review for Alzheimer’s Treatment
The Story:
The US Food and Drug Administration (FDA) has agreed to grant priority review to Biogen's new Alzheimer's medication, aducanumab. If approved, aducanumab will...
Health: The Unintended Consequences of a Biogen Meeting
The Story:
In late February, the biopharm giant Biogen held a conference in Boston that researchers into the ongoing pandemic now see as a "superspreader"...